Su1752 EFFICACY AND SAFETY OF LIRAGLUTIDE IN PATIENTS WITH PATIENTS WITH AN ILEAL -POUCH-ANAL ANASTOMOSIS (IPAA) AND CHRONIC HIGH BOWEL FREQUENCY – PLACEBO-CONTROLLED, CROSSOVER, PROOF OF CONCEPT STUDY
Hans Herfarth(University of North Carolina at Chapel Hill), Edward L. Barnes(University of North Carolina at Chapel Hill), Emily English(University of North Carolina at Chapel Hill), Chelsea Anderson(University of North Carolina at Chapel Hill), John B. Buse(Unknown), Millie D. Long(University of North Carolina Health Care)
Cited by 0
Related Papers
Management of Hyperglycemia in Type 2 Diabetes, 2018. A Consensus Report by the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD)
|Diabetes Care|2018|3.5k
Effects of Once-Weekly Exenatide on Cardiovascular Outcomes in Type 2 Diabetes
|New England Journal of Medicine|2017|2.1k
Management of Hyperglycemia in Type 2 Diabetes, 2022. A Consensus Report by the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD)
|Diabetes Care|2022|1.9k
Burden and Cost of Gastrointestinal, Liver, and Pancreatic Diseases in the United States: Update 2018
|Gastroenterology|2018|1.7k
ACG Clinical Guideline: Ulcerative Colitis in Adults
|The American Journal of Gastroenterology|2019|1.6k